Soluble P-selectin Stem Cell Mobilization
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for stem cell mobilization, such as using AMD3100 or G-CSF, are not sufficient for effectively mobilizing hematopoietic stem cells for therapeutic applications like wound healing and tissue regeneration, necessitating the development of a more efficient agent.
Innovation Solution
Administration of soluble P-selectin (sP-sel) to interfere with the interaction between stem cells and their niches, enhancing their release, circulation, and migration, which can be combined with other agents like G-CSF for enhanced mobilization.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If AMD3100 or G-CSF is used for stem cell mobilization, then stem cells are released into circulation, but the mobilization efficiency is insufficient for therapeutic applications
Solution Approach 1:
The patent uses soluble P-selectin (sP-sel) as an intermediary molecule to block the interaction between P-selectin on endothelial cells and its ligands on stem cells. This mediator approach disrupts the anchoring mechanism that retains stem cells in bone marrow, enabling their release into circulation with higher efficiency than existing mobilization agents.
2Ease of operation
If stem cells are mobilized into peripheral blood, then they can be harvested for transplantation, but the interaction with niches must be disrupted effectively
Solution Approach 1:
The patent extracts and isolates the P-selectin interaction mechanism as the key factor maintaining stem cells in bone marrow niches. By using soluble P-selectin to specifically block this interaction, the patent simplifies the mobilization process by targeting and removing the primary anchoring mechanism, making stem cell harvesting more straightforward.
3Reliability
If soluble P-selectin is administered to mobilize stem cells, then tissue repair and regeneration are enhanced, but the dosage and administration timing must be optimized
Solution Approach 1:
The patent establishes specific dosage ranges (10-5 μg to 1.5 mg per kg body weight per administration) and administration protocols for soluble P-selectin. By optimizing these parameters, the patent achieves reliable therapeutic effects while providing flexibility in dosing regimens to adapt to different clinical scenarios and patient needs.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Soluble P-selectin effectively mobilizes hematopoietic stem cells, promoting tissue repair, revascularization, and repopulation of bone marrow, offering therapeutic benefits for various pathologies including liver damage, inflammatory diseases, and metabolic disorders.
Implementation Method 1
soluble P-selectin (sP-sel) to interfere with the interaction between stem cells and their niches, enhancing their release, circulation, and migration
Data Source
AI summary
The present disclosure provides a soluble P-selectin (sP-sel) interfering the interaction between stem cells and niches to mobilize stem cells from bone marrow. The mobilization of stem cells with sP-sel can treat a subject in need of preservation, repair, or regeneration of a tissue, or revascularization.